Call for Tighter Control on Drug Ads
May 18, 2008
AMA Calls For Tighter Drug Ad Oversight
Critics have long pointed out that consumers are in no position to purchase prescription drugs without their doctor. The sole point of advertising to consumers, they claim, is to prompt consumers to specifically request a particular prescription drug.
At the hearing, the AMA discussed the need for FDA regulation over DTCA and shared guidelines for DTCA that address advertising content, disclosures, and audiences targeted.
“The AMA guidelines for DTCA can help ensure that patients receive information about prescription drugs that is accurate, educational, well-balanced and encourages patient-physician communication,” Nielsen said.